drugset / Trial / NCT00440713

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms

NCT00440713

Phase 3 Completed 40 enrolled Federal University of São Paulo
RandomizedSingle-groupSingle-blindTreatment

Summary

32 outpatients with a Posttraumatic Stress Disorder were included in a randomized comparative single-blind study to study the efficacy of aripiprazole to treat post-traumatic stress symptoms. The hypothesis is that aripiprazole has an efficacy to reduce PTSD symptoms

Timeline

Start
2004-01
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified